Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

Disorders of Leukocytes

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Insulin resistance metabolomic profile in non-diabetic women with systemic lupus erythematosus.

Gaceta medica de Mexico·2022

Same author

Vitamin D in systemic lupus erythematosus with and without lupus nephritis.

Revista medica del Instituto Mexicano del Seguro Social·2021

Same author

Treatment of Persons with Multiple Myeloma in Underprivileged Circumstances: Real-World Data from a Single Institution.

Acta haematologica·2020

Same author

25-Hydroxyvitamin D concentrations and risk of metabolic syndrome in systemic lupus erythematosus women.

International journal of rheumatic diseases·2019

Same author

Systemic lupus erythematosus and hypertension.

Autoimmunity reviews·2019

Same author

Determine safety of outpatient chemotherapy and autotransplants using refrigerated, non-frozen grafts in persons with multiple sclerosis.

Clinical transplantation·2019

Search research articles

Related Experiment Video

Updated: May 23, 2026

Identification of Quiescent Cells in a Zebrafish T-Cell Acute Lymphoblastic Leukemia Model Using Cell Proliferation Staining

Identification of Quiescent Cells in a Zebrafish T-Cell Acute Lymphoblastic Leukemia Model Using Cell Proliferation Staining

Published on: July 19, 2024

Donor cell leukemia.

Alejandro Ruiz-Arguelles¹

¹Laboratorios Clínicos de Puebla, Universidad Popular Autónoma del Estado de Puebla, Puebla, Mexico. aruiz@clinicaruiz.com

Hematology (Amsterdam, Netherlands)

|April 18, 2012

Summary

Detecting minimal residual disease (MRD) is crucial for guiding cancer treatment decisions. Reliable methods are essential for accurately identifying these residual tumor cells to optimize patient therapy.

Area of Science:

Hematology
Oncology
Clinical Pathology

Background:

Minimal residual disease (MRD) comprises residual neoplastic cells post-therapy, impacting treatment continuation or withdrawal.
Accurate detection and quantification of MRD are critical for clinical decision-making in oncology.
Current methods for MRD detection face challenges in sensitivity, specificity, and applicability across all leukemia types.

Purpose of the Study:

To discuss the significance of minimal residual disease detection in clinical practice.
To review the methodologies employed for identifying and quantifying residual neoplastic cells.
To address the complexities and controversies surrounding MRD assessment in leukemia.

Main Methods:

Discussion of flow cytometry as a widely used technique for MRD detection.

More Related Videos

In Ovo Xenografting of Patient-Derived Acute Lymphoblastic Leukemia (ALL) Cells (PDX-ALL)

In Ovo Xenografting of Patient-Derived Acute Lymphoblastic Leukemia (ALL) Cells (PDX-ALL)

Published on: August 1, 2025

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Published on: March 17, 2020

Related Experiment Videos

Last Updated: May 23, 2026

Identification of Quiescent Cells in a Zebrafish T-Cell Acute Lymphoblastic Leukemia Model Using Cell Proliferation Staining

Identification of Quiescent Cells in a Zebrafish T-Cell Acute Lymphoblastic Leukemia Model Using Cell Proliferation Staining

Published on: July 19, 2024

In Ovo Xenografting of Patient-Derived Acute Lymphoblastic Leukemia (ALL) Cells (PDX-ALL)

In Ovo Xenografting of Patient-Derived Acute Lymphoblastic Leukemia (ALL) Cells (PDX-ALL)

Published on: August 1, 2025

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Published on: March 17, 2020

Evaluation of molecular biology techniques for their high sensitivity and specificity.

Consideration of donor cell leukemia as a confounding factor in MRD assessment post-transplantation.

Main Results:

Flow cytometry's clinical utility is primarily influenced by interpretation criteria.
Molecular techniques offer high sensitivity and specificity but have limitations in patient applicability.
Donor cell leukemia can mimic MRD, complicating accurate diagnosis.

Conclusions:

Robust and sensitive methods are essential for reliable MRD detection.
The choice of method for MRD assessment depends on the specific clinical context and patient characteristics.
Further refinement of techniques and interpretation is needed to improve MRD assessment accuracy and clinical utility.